Dr. Duduzile L Musa, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 W Elm St, 2nd Floor, Conshohocken, PA 19428 Phone: 610-567-6964 Fax: 610-567-6170 |
Dr. Scott Howell Wright, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1118 Riverview Ln, Conshohocken, PA 19428 Phone: 610-525-7573 |
Dr. William Dean Lucht, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 100 E 15th Ave, Conshohocken, PA 19428 Phone: 907-317-7894 Fax: 610-825-4182 |
Dr. Michael David Overbeck, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Fayette St, Conshohocken, PA 19428 Phone: 610-828-2026 Fax: 610-828-7318 |
Sanjay Dabral, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 W Elm St, 2nd Floor, Conshohocken, PA 19428 Phone: 610-567-6964 Fax: 610-567-6170 |
Andrea Becker, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Hector St.,, Suite 105, Conshohocken, PA 19428 Phone: 610-828-2608 Fax: 610-828-0102 |
Dr. Arie Oren, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 100 W 3rd Ave, Suite 101, Conshohocken, PA 19428 Phone: 610-834-7580 Fax: 610-834-8877 |
Dr. Mathew Mathew, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 W Elm St, 2nd Floor, Conshohocken, PA 19428 Phone: 610-567-6964 Fax: 610-567-6170 |
News Archive
GenVec, Inc. today reported financial results for the first quarter ended March 31, 2015. For the three months ended March 31, 2015, GenVec reported a net loss of $1.5 million, or $0.09 per share, on revenues of $0.4 million, compared with a net loss of $1.0 million, or $0.07 per share, on revenues of $2.1 million, for the same period in the prior year.
Anabolic steroids not only make teens more aggressive, but may keep them that way into young adulthood. The effect ultimately wears off but there may be other, lasting consequences for the developing brain.
A Cambridge start-up has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time.
People with diabetes could be able to monitor their blood sugar without drawing blood using a system now being developed at the University of Waterloo.
Orexo AB announces today that an exclusive licensing and distribution agreement has been signed with NewBridge Pharmaceuticals for Abstral, Orexo´s product for the treatment of breakthrough cancer pain.
› Verified 4 days ago